Streetbeat News

Earnings

YOSH

Yoshiharu Global reported a significant increase in Q2 revenue, reaching $3.3 million, up from $2.2 million year-over-year.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 12:32 pm

LOW

Lowe's Companies, Inc. (NYSE:LOW) is set to release its Q2 earnings report on Aug. 20, with expected earnings of $3.97 per share, down from $4.56 last year. The company projects quarterly revenue of $23.91 billion. Lowe's offers a 1.91% annual dividend yield, translating to $1.15 per share quarterly. To earn $500 monthly from dividends, an investment of approximately $314,460 is needed. Analyst Joseph Feldman maintains a Market Perform rating with a $230 price target.

Portfolio Pulse from Avi Kapoor

August 19, 2024 | 12:24 pm

BCDA

BioCardia shares are trading higher after the company reported better-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 12:17 pm

FLYE

Fly-E Group reported an EPS of $(0.01) compared to $(0.02) year-over-year, and revenue of $7.9 million compared to $7.8 million year-over-year.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 12:13 pm

SBFM

Sunshine Biopharma (NASDAQ:SBFM) reported Q2 earnings per share (EPS) of $(9.94), significantly missing the analyst estimate of $(0.37). However, the company reported sales of $9.30 million, beating the estimate of $9.00 million.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 12:12 pm

LZM

Lifezone Metals (NYSE:LZM) reported a Q3 2024 GAAP EPS of $(0.14), missing the analyst consensus estimate of $(0.05) by 180%.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 12:11 pm

TNXP

Tonix Pharmaceuticals shares are trading higher following the company's Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 12:11 pm

LZM

Lifezone Metals Limited (NYSE:LZM) reported a reduced loss per share of $0.14 for H1 2024, down from $0.18 in H1 2023. The company is progressing its Kabanga Nickel Project in Tanzania, with the Definitive Feasibility Study expected to be completed by the end of September. Lifezone is also advancing a partnership with Glencore to recycle platinum, palladium, and rhodium in the U.S. The company maintains a healthy cash position of $63.5 million as of June 30, 2024.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 12:10 pm

MICS

The Singing Machine Company reported its Q2 2024 earnings per share (EPS) at $(0.95), a decline from $(0.64) year-over-year (YoY). Revenue also decreased to $2.44 million from $2.625 million YoY.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 12:09 pm

OVID

In the last three months, 7 analysts have provided ratings for Ovid Therapeutics (NASDAQ: OVID), with 6 being bullish and 1 indifferent. The average 12-month price target has decreased by 48.9% to $3.03. Analysts have adjusted their ratings and price targets in response to market dynamics and company performance. Ovid Therapeutics has shown strong financial performance with significant revenue growth, high net margin, and efficient use of assets.

Portfolio Pulse from Benzinga Insights

August 19, 2024 | 12:00 pm